FR3429M - Nouvel antibiotique ussamycine utilisable en thérapeutique. - Google Patents

Nouvel antibiotique ussamycine utilisable en thérapeutique.

Info

Publication number
FR3429M
FR3429M FR976291A FR976291A FR3429M FR 3429 M FR3429 M FR 3429M FR 976291 A FR976291 A FR 976291A FR 976291 A FR976291 A FR 976291A FR 3429 M FR3429 M FR 3429M
Authority
FR
France
Prior art keywords
ussamycin
usable
therapy
new antibiotic
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR976291A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR968013A external-priority patent/FR1404466A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3429M publication Critical patent/FR3429M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/56—Streptomyces lavendulae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR976291A 1963-03-27 1964-05-29 Nouvel antibiotique ussamycine utilisable en thérapeutique. Active FR3429M (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH390663 1963-03-27
CH516263 1963-04-24
FR968013A FR1404466A (fr) 1963-03-27 1964-03-20 Nouvel antibiotique, à partir d'une mutation d'une souche de streptomyces lavendulae et procédé pour sa préparation

Publications (1)

Publication Number Publication Date
FR3429M true FR3429M (fr) 1965-07-12

Family

ID=25694139

Family Applications (1)

Application Number Title Priority Date Filing Date
FR976291A Active FR3429M (fr) 1963-03-27 1964-05-29 Nouvel antibiotique ussamycine utilisable en thérapeutique.

Country Status (6)

Country Link
BE (1) BE645730A (fr)
DE (1) DE1208449B (fr)
ES (1) ES298011A1 (fr)
FR (1) FR3429M (fr)
GB (1) GB1060444A (fr)
NL (1) NL6403317A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402665A1 (fr) * 1977-09-12 1979-04-06 Arai Tadashi Nouveaux antibiotiques et leur procede de preparation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221625A (en) * 1992-01-10 1993-06-22 Merck & Co., Inc. Cyclcic FR-900520 microbial biotransformation agent
US5268282A (en) * 1992-09-28 1993-12-07 Merck & Co., Inc. Cyclic FR-900520 microbial biotransformation agent
US5268281A (en) * 1992-09-28 1993-12-07 Merck & Co., Inc. Cyclic FR-900520 microbial biotransformation agent
US5283183A (en) * 1992-09-28 1994-02-01 Merck & Co., Inc. Cyclic FR-900520 microbial biotransformation agent
US5290689A (en) * 1992-09-28 1994-03-01 Merck & Co., Inc. New cyclic FR-900520 microbial biotransformation agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402665A1 (fr) * 1977-09-12 1979-04-06 Arai Tadashi Nouveaux antibiotiques et leur procede de preparation

Also Published As

Publication number Publication date
GB1060444A (en) 1967-03-01
ES298011A1 (es) 1964-12-01
BE645730A (fr) 1964-09-28
NL6403317A (fr) 1964-09-28
DE1208449B (de) 1966-01-05

Similar Documents

Publication Publication Date Title
DK101572C (da) Byggesæt.
DK115947B (da) Vagitorium.
DK105902C (da) Metalbor.
DK112538B (da) Krydsfelt-stikkontaktbord.
FR3429M (fr) Nouvel antibiotique ussamycine utilisable en thérapeutique.
FR3377M (fr) Pommade utilisable en ophtalmologie.
NL144722B (nl) Balanceerinrichting.
DK107717C (da) Pattegummi.
NL148116B (nl) Weeflis.
FR3817M (fr) Nouvel anthelmintique.
NL142260B (nl) Inhoud-geadresseerd geheugen.
DK115762B (da) Brevordner.
FR3676M (fr) Nouvel antibiotique tuoromycine utilisable en thérapeutique.
NL144671B (nl) Spindop.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
CH407502A (de) Mehrscheibenverglasung
FR1396089A (fr) Ejecto-convecteur double
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR1476623A (fr) Vinylbenzimidazoles alpha, beta-disubstitués
FR1408052A (fr) étireuses-retordeuses, et machines similaires
FR3642M (fr) Nouvel antibiotique, la tétrahexine, utilisable notamment en dermatologie.
AT244279B (de) Walzenanordnung
DK106830C (da) Trawlskovl.
ES98038Y (es) Caja-envase.
DK108299C (da) Bundtrawl.